Non small cell lung cancer

Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small cell carcinoma. When possible, they are primarily treated by surgical resection with curative intent, although chemotherapy is increasingly being used both pre-operatively (neoadjuvant chemotherapy) and post-operatively (adjuvant chemotherapy).

Chinese herbs show promise for lung cancer, flu, and idiopathic pulmonary fibrosis

Experimental drugs for breast cancer could treat lung cancer too

American Society of Clinical Oncology issues annual report on progress against cancer

Lung cancer patients live longer if they use beta-blockers while receiving radiotherapy

New research gives hope to women with deadliest breast cancer

FDA approves new drug for advanced lung cancer

Targeted therapy boosts lung cancer outcomes

Experimental drug beneficial in NIH trial to treat a rare sarcoma

New therapy on the horizon for ALK+ non-small cell lung cancer

New therapy is tolerable in lung cancer